Search Results - "D'Incà, Renata"

Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator by Cingolani, Linda, Barberio, Brigida, Zingone, Fabiana, Ferronato, Antonio, Bertani, Lorenzo, Costa, Francesco, Bodini, Giorgia, Demarzo, Maria Giulia, Melatti, Piera, Gubbiotti, Alessandro, Massimi, Davide, Casadei, Cesare, D’Incà, Renata, Savarino, Edoardo Vincenzo

“…To date, data on effectiveness and safety of Adalimumab (ADA) biosimilars in inflammatory bowel diseases (IBDs) are lacking. Therefore, we aimed to verify the…”
Get full text

Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease by Latiano, Anna, Palmieri, Orazio, Pastorelli, Luca, Vecchi, Maurizio, Pizarro, Theresa T, Bossa, Fabrizio, Merla, Giuseppe, Augello, Bartolomeo, Latiano, Tiziana, Corritore, Giuseppe, Settesoldi, Alessia, Valvano, Maria Rosa, D'Incà, Renata, Stronati, Laura, Annese, Vito, Andriulli, Angelo

“…Recent evidence suggests that the IL-33/IL1RL1 axis plays a critical role in several autoimmune and inflammatory disorders; however, its mechanistic role in…”
Get full text

Colorectal cancer and inflammatory bowel diseases share common salivary proteomic pathways by Contran, Nicole, Arrigoni, Giorgio, Battisti, Ilaria, D’Incà, Renata, Angriman, Imerio, Franchin, Cinzia, Scapellato, Maria L., Padoan, Andrea, Moz, Stefania, Aita, Ada, Savarino, Edoardo, Lorenzon, Greta, Zingone, Fabiana, Spolverato, Gaya, Pucciarelli, Salvatore, Nordi, Evelyn, Galozzi, Paola, Basso, Daniela

“…Inflammatory bowels diseases (IBD) are high risk conditions for colorectal cancer (CRC). The discovery of IBD and CRC noninvasive protein/peptide biomarkers…”
Get full text

Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case–Control IG-IBD Study by Biancone, Livia, Armuzzi, Alessandro, Scribano, Maria Lia, Castiglione, Fabiana, D’Incà, Renata, Orlando, Ambrogio, Papi, Claudio, Daperno, Marco, Vecchi, Maurizio, Riegler, Gabriele, Fries, Walter, Alvisi, Patrizia, Meucci, Gianmichele, Mocciaro, Filippo, Rogai, Francesca, Festa, Stefano, Guidi, Luisa, Testa, Anna, Spina, Luisa, Renna, Sara, Viola, Anna, Patturelli, Marta, Di Mitri, Roberto, Frankovic, Iris, Calabrese, Emma, Petruzziello, Carmelina, De Cristofaro, Elena, Sena, Giorgia, Ruffa, Alessandra, Neri, Benedetto, Rossi, Alessandra

“…Abstract Background In a 6-year, multicenter, prospective nested case–control study, we aimed to evaluate risk factors for incident cancer in inflammatory…”
Get full text

Crohn's Disease Localization Displays Different Predisposing Genetic Variants by Palmieri, Orazio, Bossa, Fabrizio, Valvano, Maria Rosa, Corritore, Giuseppe, Latiano, Tiziana, Martino, Giuseppina, D'Incà, Renata, Cucchiara, Salvatore, Pastore, Maria, D'Altilia, Mario, Scimeca, Daniela, Biscaglia, Giuseppe, Andriulli, Angelo, Latiano, Anna

“…Crohn's disease (CD) is a pathologic condition with different clinical expressions that may reflect an interplay between genetics and environmental factors…”
Get full text

Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease by Gionchetti, Paolo, Rizzello, Fernando, Annese, Vito, Armuzzi, Alessandro, Biancone, Livia, Castiglione, Fabiana, Comberlato, Michele, Cottone, Mario, Danese, Silvio, Daperno, Marco, D’Incà, Renata, Fries, Walter, Kohn, Anna, Orlando, Ambrogio, Papi, Claudio, Vecchi, Maurizio, Ardizzone, Sandro

“…Abstract The two main forms of intestinal bowel disease, namely ulcerative colitis and Crohn’s disease, are not curable but can be controlled by various…”
Get full text

Good efficacy and safety of vedolizumab in Crohn’s disease and ulcerative colitis in a real-world scenario by Zingone, Fabiana, Barberio, Brigida, Compostella, Federico, Girardin, Giulia, D’Incà, Renata, Marinelli, Carla, Marsilio, Ilaria, Lorenzon, Greta, Savarino, Edoardo Vincenzo

“…Background: Data on vedolizumab (VDZ) use in inflammatory bowel disease (IBD) patients are still limited. We aimed to assess the effectiveness and tolerability…”
Get full text

Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study by Viola, Anna, Pugliese, Daniela, Renna, Sara, Furfaro, Federica, Caprioli, Flavio, D’Incà, Renata, Bossa, Fabrizio, Mazza, Stefano, Costantino, Giuseppe, Fantini, Massimo Claudio, Fiorino, Gionata, Alibrandi, Angela, Orlando, Ambrogio, Armuzzi, Alessandro, Fries, Walter

“…Anti-TNF therapies infliximab (IFX), adalimumab (ADA), and golimumab (GOL) are approved for treating moderate to severe ulcerative colitis (UC). In UC, only…”
Get full text

Oral administration of Lactobacillus casei DG® after ileostomy closure in restorative proctocolectomy: a randomized placebo-controlled trial (microbiota and immune microenvironment in pouchitis -MEP1) by Angriman, Imerio, Scarpa, Melania, Savarino, Edoardo, Patuzzi, Ilaria, Rigo, Alessandra, Kotsafti, Andromachi, Stepanyan, Astghik, Sciuto, Elisa, Celotto, Francesco, Negro, Silvia, Caruso, Antonino, Ruffolo, Cesare, Bardini, Romeo, Pucciarelli, Salvatore, Barberio, Brigida, Spolverato, Gaya, Zingone, Fabiana, D'Incà, Renata, Castagliuolo, Ignazio, Scarpa, Marco

“…Pouchitis is an idiopathic inflammatory disease that may occur in ileal pouches, and it can lead to ileal pouch failure. This was a single-center, randomized,…”
Get full text

MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis by Pathak, Surajit, Grillo, Alessia Rosaria, Scarpa, Melania, Brun, Paola, D'Incà, Renata, Nai, Laura, Banerjee, Antara, Cavallo, Donatella, Barzon, Luisa, Palù, Giorgio, Sturniolo, Giacomo Carlo, Buda, Andrea, Castagliuolo, Ignazio

“…Abnormal levels of microRNA (miR)-155, which regulate inflammation and immune responses, have been demonstrated in the colonic mucosa of patients with…”
Get full text

Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study by Massimi, Davide, Barberio, Brigida, Bertani, Lorenzo, Costa, Francesco, Ferronato, Antonio, Facchin, Sonia, Cardin, Romilda, Cingolani, Linda, Casadei, Cesare, D’Incà, Renata, Zingone, Fabiana, Savarino, Edoardo Vincenzo

“…Background: Current literature still lacks studies evaluating the effectiveness and safety of switching from Infliximab originator to SB2 biosimilar in…”
Get full text

Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease? by D'INCA, Renata, DAL PONT, Elisabetta, DI LEO, Vincenza, BENAZZATO, Luca, MARTINATO, Matteo, LAMBOGLIA, Francesca, OLIVA, Lydia, CARLO STURNIOLO, Giacomo

“…Assessing the clinical course of inflammatory bowel disease (IBD) patients consists of periodical clinical evaluations and laboratory tests. We aimed to assess…”
Get full text

Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital by Barberio, Brigida, Facchin, Sonia, Mele, Edoardo, D’Incà, Renata, Sturniolo, Giacomo Carlo, Farinati, Fabio, Zingone, Fabiana, Quagliariello, Andrea, Ghisa, Matteo, Massimi, Davide, Casadei, Cesare, Savarino, Edoardo Vincenzo

“…Background: Faecal microbiota transplantation (FMT) is a reasonable therapeutic option for the treatment of Clostridioides difficile infection (CDI) recurrent…”
Get full text

Confocal laser endomicroscopy for prediction of disease relapse in ulcerative colitis: A pilot study by Buda, Andrea, Hatem, Giorgia, Neumann, Helmut, D' Incà, Renata, Mescoli, Claudia, Piselli, Pierluca, Jackson, John, Bruno, Marco, Sturniolo, Giacomo Carlo

“…Neoangiogenesis and increased endothelial permeability are observed as results of chronic intestinal inflammation. However, limited data on microvascular and…”
Get full text

Incident Colorectal Cancer in Inflammatory Bowel Disease by Neri, Benedetto, Scribano, Maria Lia, Armuzzi, Alessandro, Castiglione, Fabiana, D'Incà, Renata, Orlando, Ambrogio, Festa, Stefano, Riegler, Gabriele, Fries, Walter, Meucci, Gianmichele, Alvisi, Patrizia, Mocciaro, Filippo, Papi, Claudio, Mossa, Michelangela, Sena, Giorgia, Guidi, Luisa, Testa, Anna, Renna, Sara, Frankovic, Iris, Viola, Anna, Patturelli, Marta, Chiaramonte, Carlo, Biancone, Livia, On Behalf Of Ig-Ibd Italian Group For The Study Of Inflammatory Bowel Disease

“…Colorectal cancer (CRC) risk is increased in Inflammatory Bowel Disease (IBD) and surveillance needs to be tailored according to individual risk. The open…”
Get full text

Late-onset Crohn’s disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease ‘AGED’ study by Viola, Anna, Monterubbianesi, Rita, Scalisi, Giuseppe, Furfaro, Federica, Rea, Matilde, Saibeni, Simone, Aratari, Annalisa, Bringiotti, Roberto, Casella, Giovanni, Cantoro, Laura, Frankovic, Iris, Calella, Francesca, Pugliese, Daniela, Orlando, Stefania, Samperi, Leonardo, Cappello, Maria, Mocci, Giammarco, Manetti, Natalia, Annese, Vito, Privitera, Antonino C, Inserra, Gaetano, Caprioli, Flavio, D’Incà, Renata, Principi, Mariabeatrice, Papi, Claudio, Castiglione, Fabiana, Danese, Silvio, Ardizzone, Sandro, Bossa, Fabrizio, Kohn, Anna, Manguso, Francesco, Alibrandi, Angela, Fiorino, Gionata, Armuzzi, Alessandro, Fries, Walter

“…BACKGROUND:Disease phenotype and outcome of late-onset Crohn’s disease are still poorly defined. METHODS:In this Italian nationwide multicentre retrospective…”
Get full text

Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut by Michielan, Andrea, D’Incà, Renata

“…The pathogenesis of inflammatory bowel disease (IBD) is multifactorial with data suggesting the role of a disturbed interaction between the gut and the…”
Get full text

Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease by Lenti, Marco Vincenzo, Scribano, Maria Lia, Biancone, Livia, Ciccocioppo, Rachele, Pugliese, Daniela, Pastorelli, Luca, Fiorino, Gionata, Savarino, Edoardo, Caprioli, Flavio Andrea, Ardizzone, Sandro, Fantini, Massimo Claudio, Tontini, Gian Eugenio, Orlando, Ambrogio, Sampietro, Gianluca Matteo, Sturniolo, Giacomo Carlo, Monteleone, Giovanni, Vecchi, Maurizio, Kohn, Anna, Daperno, Marco, D'Incà, Renata, Corazza, Gino Roberto, Di Sabatino, Antonio

“…Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), is a complex, immune-mediated, disorder which leads to…”
Get full text

Investigation of multiple susceptibility loci for inflammatory bowel disease in an Italian cohort of patients by Latiano, Anna, Palmieri, Orazio, Latiano, Tiziana, Corritore, Giuseppe, Bossa, Fabrizio, Martino, Giuseppina, Biscaglia, Giuseppe, Scimeca, Daniela, Valvano, Maria Rosa, Pastore, Maria, Marseglia, Antonio, D'Incà, Renata, Andriulli, Angelo, Annese, Vito

“…Recent GWAs and meta-analyses have outlined about 100 susceptibility genes/loci for inflammatory bowel diseases (IBD). In this study we aimed to investigate…”
Get full text

Separation of Low- Versus High-grade Crohn’s Disease-associated Small Bowel Carcinomas is Improved by Invasive Front Prognostic Marker Analysis by Arpa, Giovanni, Grillo, Federica, Giuffrida, Paolo, Nesi, Gabriella, Klersy, Catherine, Mescoli, Claudia, Lenti, Marco Vincenzo, Lobascio, Gessica, Martino, Michele, Latella, Giovanni, Malvi, Deborah, Macciomei, Maria Cristina, Fociani, Paolo, Villanacci, Vincenzo, Rizzo, Aroldo, Ferrero, Stefano, Sessa, Fausto, Orlandi, Augusto, Monteleone, Giovanni, Biancone, Livia, Cantoro, Laura, Tonelli, Francesco, Ciardi, Antonio, Poggioli, Gilberto, Rizzello, Fernando, Ardizzone, Sandro, Sampietro, Gianluca, Solina, Gaspare, Oreggia, Barbara, Papi, Claudio, D’Incà, Renata, Vecchi, Maurizio, Caprioli, Flavio, Caronna, Roberto, D’Errico, Antonietta, Fiocca, Roberto, Rugge, Massimo, Corazza, Gino Roberto, Luinetti, Ombretta, Paulli, Marco, Solcia, Enrico, Di Sabatino, Antonio, Vanoli, Alessandro

“…Abstract Background and Aims Crohn’s disease-associated small bowel carcinoma is a rare event, usually reported to have a severe prognosis. However, in…”
Get full text